16 research outputs found

    Effect of rolipram and LASSBio-448 on ovalbumin (OVA)-induced infiltration of eosinophils in the lung tissue from A/J mice.

    No full text
    <p>Animals were sensitized on days 0 and 7 and then challenged with OVA (25 μg/mouse) or saline on days 14, 21, 28 and 35. Animals were treated with rolipram (10 mg/Kg, oral) or LASSBio-448 (100 mg/Kg, oral) on days 26 and 22, 1 h before OVA challenge, and analyses performed 24 h after the last challenge. Values represent mean ± SEM from at least 7 animals. + P<0.05 as compared to saline-challenged group; *<i>P</i><0.05 as compared to OVA-challenged group.</p

    Eukaryotic linear motifs of several Mps1 plant orthologs.

    No full text
    <p>Color codes: LIG_APCC_Dbox_1 (light green); Cyclin recognition site LIG_CYCLIN_1 (cyan); MAD2 binding motif LIG_MAD2 (orange); MAPK docking motif LIG_MAPK_1 (blue), NES Nuclear Export Signal TRG_NES_CRM1_1 (red), NLS classical Nuclear Localization Signals (green). AtMps1 (<i>A. thaliana</i>; 28416703); PtMps1 (<i>P. trichocarpa</i>; 224063138); RcMps1 (<i>R. communis</i>; 255545510); OsMps1 (<i>O. sativa</i> Indica Group; 125545426); SbMps1 (<i>S. bicolor</i>; 242038411).</p

    Effect of rolipram and LASSBio-448 on ovalbumin (OVA)-induced changes in lungs from A/J mice.

    No full text
    <p>Airway responsiveness was measured by changes in airway resistance (A) and elastance (B) induced by increasing concentrations of methacholine, 24 h after the last ovalbumin or saline challenge. Animals were sensitized on days 0 and 7 and then challenged with OVA (25 μg/mouse) or saline on days 14, 21, 28 and 35. Animals were treated with rolipram (10 mg/Kg, oral) or LASSBio-448 (100 mg/Kg, oral) on days 26 and 22, 1 h before OVA challenge, and analyses performed 24 h after the last challenge. Values represent mean ± SEM from at least 7 animals. + <i>P</i><0.05 as compared to saline-challenged group; *<i>P</i><0.05 as compared to OVA-challenged group.</p

    Structural and Functional Characterization of the Protein Kinase Mps1 in <em>Arabidopsis thaliana</em>

    Get PDF
    <div><p>In eukaryotes, protein kinases catalyze the transfer of a gamma-phosphate from ATP (or GTP) to specific amino acids in protein targets. In plants, protein kinases have been shown to participate in signaling cascades driving responses to environmental stimuli and developmental processes. Plant meristems are undifferentiated tissues that provide the major source of cells that will form organs throughout development. However, non-dividing specialized cells can also dedifferentiate and re-initiate cell division if exposed to appropriate conditions. Mps1 (<b>M</b>ono<b>p</b>olar <b>s</b>pindle) is a dual-specificity protein kinase that plays a critical role in monitoring the accuracy of chromosome segregation in the mitotic checkpoint mechanism. Although Mps1 functions have been clearly demonstrated in animals and fungi, its role in plants is so far unclear. Here, using structural and biochemical analyses here we show that Mps1 has highly similar homologs in many plant genomes across distinct lineages (e.g. AtMps1 in <em>Arabidopsis thaliana</em>). Several structural features (i.e. catalytic site, DFG motif and threonine triad) are clearly conserved in plant Mps1 kinases. Structural and sequence analysis also suggest that AtMps1 interact with other cell cycle proteins, such as Mad2 and MAPK1. By using a very specific Mps1 inhibitor (SP600125) we show that compromised AtMps1 activity hampers the development of <em>A. thaliana</em> seedlings in a dose-dependent manner, especially in secondary roots. Moreover, concomitant administration of the auxin IAA neutralizes the AtMps1 inhibition phenotype, allowing secondary root development. These observations let us to hypothesize that AtMps1 might be a downstream regulator of IAA signaling in the formation of secondary roots. Our results indicate that Mps1 might be a universal component of the Spindle Assembly Checkpoint machinery across very distant lineages of eukaryotes.</p> </div

    Synthesis sulfonamide derivatives.

    No full text
    <p>Reagents and conditions: a) 1) H<sub>2</sub>SO<sub>4</sub> /Ac<sub>2</sub>O /AcOEt, 0°C, 2 h; 2) AcOK / EtOH, 25°C, 30 min, 93%. b) SOCl<sub>2</sub>, DMF, 75°C, 4 h, 92%. c) CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, 2-(3,4-dimethoxyphenyl)ethanamine (<b>6a</b>) or 2-phenylethanamine (5), 25°C, 2–2.5 h, 70%-81% respectively. d) K<sub>2</sub>CO<sub>3</sub>, acetone, RX (X = I, Br), (<b>6b-6e, 6g-6i</b> and <b>6k</b>), 40°C, 1.5 h, 34–96%. e) CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, 2-(3,4-dimethoxyphenyl)ethanamine (<b>6f, 6j</b>) 25°C, 2–2.5 h, 53%-83% respectively.</p
    corecore